Format

Send to:

Choose Destination
See comment in PubMed Commons below
Adv Immunol. 2010;106:21-59. doi: 10.1016/S0065-2776(10)06002-5.

Nuclear receptors, inflammation, and neurodegenerative diseases.

Author information

  • 1Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA.

Abstract

Chronic inflammation is associated with many neurodegenerative diseases, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. Increasing evidence that neuroinflammation contributes to disease severity has generated considerable interest in determining whether inhibition of inflammation pathways might be of therapeutic benefit. One potential avenue of intervention is provided by members of the nuclear receptor superfamily of ligand-dependent transcription factors that exert anti-inflammatory effects in many cell types. Here, we review recent studies providing insights into the distinct mechanisms that enable nuclear receptors to modulate immune responses, describe inflammatory components of neurodegenerative diseases, and discuss recent literature relevant to roles of nuclear receptors in influencing these processes.

PMID:
20728023
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk